Related Experiment Videos
Tumour necrosis factor in B chronic lymphocytic leukaemia
British Journal of Haematology
|February 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling study.
bioRxiv : the preprint server for biology·2025
Incorporating diverse values of nature in decision-making-theory and practice.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2024
Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes
Current oncology (Toronto, Ont.)·2020
Acute steroid myopathy: a highly overlooked entity.
QJM : monthly journal of the Association of Physicians·2018
Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.
British journal of haematology·2026
Distinct clinical and genetic characteristics of myelodysplastic syndrome in younger patients.
British journal of haematology·2026
Enhanced prognosis of acute myeloid leukaemia patients with dmCEBPAbZIP -inf mutations: Insights from a multicentre Chinese cohort study.
British journal of haematology·2026
Use of selective serotonin reuptake inhibitors and risk of myeloid malignancy: A nationwide Danish case-control study.
British journal of haematology·2026
BrECADD in three days: Implementation of a condensed intensive first-line regimen in Hodgkin lymphoma.
British journal of haematology·2026
Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.
JTO clinical and research reports·2026
Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
B-cells in breast cancer: current insights and challenges.
Frontiers in oncology·2026
The heterogeneous and dynamic immune-tumor interface in breast cancer.
Frontiers in oncology·2026